BioSpace News Archive

Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced a supply agreement with the Government of the Republic of Botswana for Moderna’s vaccine against COVID-19, to support the government’s ongoing efforts to secure access to a COVID-19 vaccines for the people of Botswana

Michael Swartz interviewed in Authority Magazine Interview Series “5 Things We Must Do to Improve the U.S. Healthcare System

Consortium Advances Behavioral Insights and Diverse Patient Perspectives Across Product Development Lifecycle

Complementary companies come together to accelerate innovation in wheelchair-accessible transportation technology for the disability community.

The Center for Cancer and Blood Disorders (The CenterTX) and Deep Lens today announced that they will partner to deploy artificial intelligence (AI)-based clinical trial screening and enrollment solution, VIPER™, into the Texas-based network.

Extended Longevity, a Hawaii-based longevity company focused on reversing the biomarkers of aging, has received Institutional Board Approval from The Institute of Regenerative and Cellular Medicine to begin a groundbreaking study of its phytotherapeutic formulations and their effects on epigenetic aging.

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) presented analyses from its clinical studies evaluating maralixibat in patients with Alagille syndrome (ALGS) and progressive familial intrahepatic cholestasis type 2 (PFIC2), two rare liver diseases affecting children.

Buffalo-based company has now raised $11.4 million as research continues on its innovative BioPrax™ device, under evaluation for biofilm infection control

The market is estimated to grow at a CAGR of 20.5% from 2020 to 2027.

FasterCures, a center of the Milken Institute, released a set of recommendations that can be used to mobilize an early warning system for global pandemic threats.